Clinical Trial Update: PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating molecular profile-based versus standard adjuvant radiotherapy in endometrial cancer; currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Leiden University Medical Center | Conditions: Endometrial Cancer Stage I, Endometrial Cancer Stage II | Phase 3 | Status: ACTIVE_NOT_RECRUITING